{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Intraoperative Molecular Imaging in Pulmonary Resection for Lung Cancer"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "patients with lung nodules were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "eligibility criteria including patients with suspected lung adenocarcinomas. The trial was set across various institutions"
      },
      "Intervention": {
        "score": 2,
        "evidence": "patients with lung nodules were randomised to receive OTL38 (0.025mg/kg) preoperatively"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the impact of intraoperative molecular imaging (IMI) using OTL38"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the occurrence of clinically significant events (CSE)"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "patients with lung nodules were randomised"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of 110 patients recruited"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "92 were eligible for analysis"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "IMI identified 24 additional nodules, 9 of which were occult cancers"
      },
      "Harms": {
        "score": 1,
        "evidence": "No serious adverse events were reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT02872701"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 15,
    "max_score": 25
  },
  "model": "gpt-4o"
}